Call for Abstracts
Please download the abstract submission form at the bottom of the page and send the completed form to endai-79jes@convention.co.jp by E-mail.
Greetings
Manabu Muto, M.D., Ph.D.
Congress President of the 79th Annual Meeting of the Japan Esophageal Society
Professor, Department of Medical Oncology, Kyoto University Graduate School of Medicine
I hope this finds you in good health and good spirits as we enter the late autumn season.
I would also like to take this opportunity to thank you for your continued support.
The 79th Annual Meeting of the Japan Esophageal Society will be held at the Kyoto International Conference Center on Thursday, June 26th and Friday, June 27th, 2025.
The theme of this meeting is “Healthy Esophagus for Well-being: A lifetime of healthy esophagus! . As an interdisciplinary project, we are planning special events, joint projects with related academic societies, patient sessions, young researcher sessions, and future sessions, with the aim of maintaining a healthy esophagus and promoting social well-being. We hope to make this a meaningful academic conference where we can discuss a wide range of topics related to esophageal diseases and share the latest findings.
With this in mind, we would like to inform you that we have started accepting applications for both the main theme sessions and general presentations, earlier than usual.
In order to make the academic conference more fruitful, we would like to ask you to please register as many presentations as possible and help make this academic conference a success. In addition, we will be offering awards for distinguished presentations, etc., this time around at the request of President Professor Hiroya Takeuchi, so please be sure to register.
Furthermore, we have set up a Medical Staff Session, and to make it easier for medical staff to participate, medical staff who are not already members of the Japan Esophageal Society will be able to join as associate members for free for the first year, with no annual membership fee or academic meeting participation fee. We hope that you will encourage medical staff from your facility to join you.
Congress Information
| Congress | The 79th Annual Meeting of The Japan Esophageal Society |
|---|---|
| Date | June 26 (Thu.) – 27 (Fri.), 2025 |
| Venue | Kyoto International Conference Center Access: https://www.icckyoto.or.jp/en/access-2/getting_here/ |
| Congress President | Manabu Muto, M.D., Ph.D. (Professor, Department of Medical Oncology, Kyoto University Graduate School of Medicine) |
| Congress Theme | Healthy Esophagus For Well-being |
| Congress Secretariat | Japan Convention Services, Inc. 14th floor Daido Seimei Kasumigaseki Bldg. 1-4-2, Kasumigaseki,Chiyoda-ku, Tokyo 100-0013, Japan E-mail: jes79@convention.co.jp |
Abstract Submission Period
| November 25 (Mon.) – | |
| January 8 (Wed.) ,2025 (Japan Time) |
Presentation Style and Categories
- Oral Session（including video presentation）
- Poster Session: Paper style (with oral presentation)
The presentation style and categories will finally be left to the Congress President
*Distinguish abstract may be selected to the scientific program.
Categories
| Category | Theme | |
|---|---|---|
| A: Basic medicine | 1 | Molecular biology |
| 2 | Pathology | |
| 3 | Biomarker | |
| 4 | Others | |
| B: General | 1 | Epidemiology |
| 2 | Database research | |
| 3 | Translational research | |
| 4 | Artificial intelligence | |
| 5 | Prevention | |
| 6 | Medical staff | |
| 7 | Others | |
| C: Benign disease | 1 | Congenital disease |
| 2 | Hiatal hernia | |
| 3 | Esophageal diverticulum | |
| 4 | Foreign body in the esophagus | |
| 5 | Idiopathic esophageal rupture | |
| 6 | Trauma | |
| 7 | Eosinophilic esophagitis | |
| 8 | Gastroesophageal reflux disease | |
| 9 | Other esophagitis and esophageal ulcers | |
| 10 | Barrett’s esophagus | |
| 11 | Benign esophageal stricture (including post-operative stricture) | |
| 12 | Achalasia | |
| 13 | Esophageal varices | |
| 14 | Esophageal motility disorder | |
| 15 | Benign tumor of the esophagus | |
| 16 | Case report | |
| 17 | Others | |
| D: Malignant tumor | 1 | Diagnosis – Endoscopic diagnosis |
| 2 | Diagnosis – Imaging diagnosis | |
| 3 | Diagnosis – Others | |
| 4 | Treatment (surgery) – General surgical techniques | |
| 5 | Treatment (surgery) – Endoscopic surgery (thoracoscopic, laparoscopic, mediastinoscopic, etc.) | |
| 6 | Treatment (Surgery) – Robotic Surgery | |
| 7 | Treatment (surgery) – Conversion/salvage surgery | |
| 8 | Treatment (surgery) – Perioperative management | |
| 9 | Treatment (surgery) – Complications | |
| 10 | Treatment (chemotherapy) – Perioperative chemotherapy | |
| 11 | Treatment (chemotherapy) – Palliative chemotherapy | |
| 12 | Treatment (chemotherapy) – Immunotherapy | |
| 13 | Treatment (radiation therapy, chemoradiation therapy) – Curative setting | |
| 14 | Treatment (radiation therapy, chemoradiation therapy) – Palliative setting | |
| 15 | Multidisciplinary treatment | |
| 16 | Treatment (endoscopic treatment) – EMR, ESD, ELPS, etc. | |
| 17 | Treatment (endoscopic treatment) – PDT, stents, PEG, etc. | |
| 18 | Palliative care | |
| 19 | Supportive care – Nutritional management, NST | |
| 20 | Supportive care – Rehabilitation | |
| 21 | Supportive care – Team medicine | |
| 22 | Case report | |
| 23 | Others |
English Session
Symposium 1: Treatment strategy aiming for esophagus preservation in patients with esophageal cancer
Definitive chemoradiotherapy is curative intent treatment for esophageal cancer. Recently, regimens with possible high treatment effects, such as DCF and ICI combination, have been introduced in clinical practice. In patients with rectal cancer, the ‘watch and wait’ strategy based on the effect of neoadjuvant CRT or TNT attracts attention. An esophagus-preserving strategy may provide better QOL for esophageal cancer patients. In this session, please discuss the current situation of the esophagus-preserving treatment strategy for esophageal cancer.
Panel Discussion 3: Treatment selection and outcomes for GERD
GERD treatment modalities became diversified due to the development of novel drugs and modalities. In Japan, new guidelines for GERD treatment were published in 2021, and endoscopic submucosal dissection for GERD was approved by the National Insurance System in 2022. Also, several kinds of minimally invasive surgery have been reported for patients with refractory GERD. In this session, please demonstrate the advantages and disadvantages of each modality and discuss future direction.
Number of words
Language for abstract, presentation and presentation slides: English
Title: Approximately up to 15 words including spaces (80 characters)
Abstract: Approximately up to 300-400 words including spaces (2,200 characters)
Selection of abstracts
Submitted abstracts will be peer-reviewed, and acceptance and presentation style will be decided by the Program President. Notification of accepted abstracts will be sent to authors by e-mail.
Abstract Submission Form
Please download the abstract submission form and send the completed form to endai-79jes@convention.co.jp by E-mail.
Inquiries for call for abstracts
Congress Secretariat
Japan Convention Services, Inc
E mail endai-79jes@convention.co.jp